Jump to content

User:Johnskad/Plasma membrane monoamine transporter/Bibliography

From Wikipedia, the free encyclopedia

You will be compiling your bibliography and creating an outline of the changes you will make in this sandbox.


Bibliography

[edit]

Edit this section to compile the bibliography for your Wikipedia assignment. Add the name and/or notes about what each source covers, then use the "Cite" button to generate the citation for that source.

Potential sources/info

  • Nancy A. Muma and Zhen Mi 2015 6 (7), 961-969. Serotonylation and Transamidation of Other Monoamines, DOI: 10.1021/cn500329r
    • Review article that mentions PMAT. General info: PMAT is highly expressed, especially in dendrites. Expressed in locations of high monoamine concentration and said to be an alternative mechanism to the high affinity transporters. [1]
  • Nishijima H and Tomiyama M (2016) What Mechanisms Are Responsible for the Reuptake of Levodopa-Derived Dopamine in Parkinsonian Striatum? Front. Neurosci. 10:575. doi: 10.3389/fnins.2016.00575
    • Mini-review article on Parkinson's; "Organic cation transporter-3 and plasma membrane monoamine transporter, low affinity, and high-capacity transporters, also potentially uptake dopamine when high-affinity transporters do not work normally." Has a figure and CC BY license.[2] "Furthermore, low affinity monoamine transporters such as OCT-3 and PMAT may be new targets to modify dopamine metabolism for PD treatment in future studies."
  • Tomomi Furihata, Naohiko Anzai, Functional Expression of Organic Ion Transporters in Astrocytes and Their Potential as a Drug Target in the Treatment of Central Nervous System Diseases, Biological and Pharmaceutical Bulletin, 2017, Volume 40, Issue 8, Pages 1153-1160, Released on J-STAGE August 01, 2017, Online ISSN 1347-5215, Print ISSN 0918-6158, https://doi-org.byu.idm.oclc.org/10.1248/bpb.b17-00076, https://www-jstage-jst-go-jp.byu.idm.oclc.org/article/bpb/40/8/40_b17-00076/_article/-char/en
    • Astrocytes and transporters, table with substates and Km, new inhibitor (Lopinavir) [3]
    • To summarize, it is considered likely that astrocytic PMAT plays a crucial role in biogenic amine clearance in both the normal and pathological brain, thus suggesting that PMAT has significant potential to become a pharmacological target in several brain diseases.
  • Lynette C. Daws, Unfaithful neurotransmitter transporters: Focus on serotonin uptake and implications for antidepressant efficacy, Pharmacology & Therapeutics, Volume 121, Issue 1, 2009, Pages 89-99, ISSN 0163-7258, https://doi.org/10.1016/j.pharmthera.2008.10.004.[4] (https://www.sciencedirect.com/science/article/pii/S0163725808001976)
    • More new inhibitors, focus on PMAT and OCT as target for anti-depressants
    • Not free - but does have snippets of all the sections
  • Wagner, David J.; Hu, Tao; Wang, Joanne (2016-09). "Polyspecific organic cation transporters and their impact on drug intracellular levels and pharmacodynamics". Pharmacological Research. 111: 237–246. doi:10.1016/j.phrs.2016.06.002. ISSN1043-6618. PMC 5293005. PMID 27317943.[5]
    • new substrate, in table
    • Good
  • Weber, Brady L.; Beaver, Jasmin N.; Gilman, T. Lee (2022-11-20). "Summarizing studies using constitutive genetic deficiency to investigate behavioural influences of uptake 2 monoamine transporters". Basic & Clinical Pharmacology & Toxicology. 133 (5): 439–458. doi:10.1111/bcpt.13810. ISSN 1742-7835.[6]
    • sex differences, overview things for uptake 2
  • Wang, J (2016-09-19). "The plasma membrane monoamine transporter (PMAT): Structure, function, and role in organic cation disposition". Clinical Pharmacology & Therapeutics. 100 (5): 489–499. doi:10.1002/cpt.442. ISSN 0009-9236. PMC 5305120. PMID 27506881
    • POSSIBLE FIGURE
    • new inhibitor
    • GREAT SOURCE
  • Koepsell, H. (2021). General Overview of Organic Cation Transporters in Brain. In: Daws, L.C. (eds) Organic Cation Transporters in the Central Nervous System. Handbook of Experimental Pharmacology, vol 266. Springer, Cham. https://doi-org.byu.idm.oclc.org/10.1007/164_2021_449
    • some good stuff, new inhibitors, astrocytes and BBB
  • Bowman MA and Daws LC (2019) Targeting Serotonin Transporters in the Treatment of Juvenile and Adolescent Depression. Front. Neurosci. 13:156. doi: 10.3389/fnins.2019.00156
    • Depression in juveniles/adolescents, okay
  • Baye AM, Fanta TG, Siddiqui MK and Dawed AY (2021) The Genetics of Adverse Drug Outcomes in Type 2 Diabetes: A Systematic Review. Front. Genet. 12:675053. doi: 10.3389/fgene.2021.675053
    • PMAT and metformin GI disturbances
  • Antonio J. López Quiñones, Letícia Salvador Vieira and Joanne Wang Drug Metabolism and Disposition September 2022, 50 (9) 1218-1227; DOI: https://doi.org/10.1124/dmd.121.000707
    • some stuff about tumors
  • PMCID: PMC3902978 NIHMSID: NIHMS537012 PMID: 24054145 Catecholamine/Serotonin Interactions: Systems Thinking for Brain Function and Disease
    • cool figure (9.7), need to check copyright
  • Zhou M, Engel K, Wang J. Evidence for significant contribution of a newly identified monoamine transporter (PMAT) to serotonin uptake in the human brain. Biochem Pharmacol. 2007 Jan 1;73(1):147-54. doi: 10.1016/j.bcp.2006.09.008. Epub 2006 Sep 14. PMID: 17046718; PMCID: PMC1828907.
    • From talk page
    • Reference for structure
  • http://dmd.aspetjournals.org/lookup/doi/10.1124/dmd.110.032987
    • pH dependent transport
  • •Bowman, Melodi A.; Gomez, Jorge A.; Mitchell, Nathan C.; Wells, Anne M.; Vitela, Melissa; Clarke, Kyra M.; Horton, Rebecca E.; Koek, Wouter; Daws, Lynette C. (2022-08-08). "Faster Serotonin Clearance in CA3 Region of Hippocampus and Antidepressant-like Effect of Decynium-22 in Juvenile Mice Are Putatively Linked to Increased Plasma Membrane Monoamine Transporter Function: Implications for Efficacy of Antidepressants in Juveniles". Cells. 11 (15): 2454. doi:10.3390/cells11152454. ISSN 2073-4409. PMC 9368098. PMID 35954298.

References

[edit]
  1. ^ Muma, Nancy A.; Mi, Zhen (2015-07-15). "Serotonylation and Transamidation of Other Monoamines". ACS Chemical Neuroscience. 6 (7): 961–969. doi:10.1021/cn500329r. ISSN 1948-7193.
  2. ^ Nishijima, Haruo; Tomiyama, Masahiko (2016-12-15). "What Mechanisms Are Responsible for the Reuptake of Levodopa-Derived Dopamine in Parkinsonian Striatum?". Frontiers in Neuroscience. 10. doi:10.3389/fnins.2016.00575. ISSN 1662-453X. PMC 5156842. PMID 28018168.{{cite journal}}: CS1 maint: PMC format (link) CS1 maint: unflagged free DOI (link)
  3. ^ Furihata, Tomomi; Anzai, Naohiko (2017). "Functional Expression of Organic Ion Transporters in Astrocytes and Their Potential as a Drug Target in the Treatment of Central Nervous System Diseases". Biological & Pharmaceutical Bulletin. 40 (8): 1153–1160. doi:10.1248/bpb.b17-00076. ISSN 0918-6158.
  4. ^ Daws, Lynette C. (2009-01-01). "Unfaithful neurotransmitter transporters: Focus on serotonin uptake and implications for antidepressant efficacy". Pharmacology & Therapeutics. 121 (1): 89–99. doi:10.1016/j.pharmthera.2008.10.004. ISSN 0163-7258.
  5. ^ Wagner, David J.; Hu, Tao; Wang, Joanne (2016-09). "Polyspecific organic cation transporters and their impact on drug intracellular levels and pharmacodynamics". Pharmacological Research. 111: 237–246. doi:10.1016/j.phrs.2016.06.002. {{cite journal}}: Check date values in: |date= (help)
  6. ^ Weber, Brady L.; Beaver, Jasmin N.; Gilman, T. Lee (2022-11-20). "Summarizing studies using constitutive genetic deficiency to investigate behavioural influences of uptake 2 monoamine transporters". Basic & Clinical Pharmacology & Toxicology. 133 (5): 439–458. doi:10.1111/bcpt.13810. ISSN 1742-7835.

Outline of proposed changes

[edit]

Click on the edit button to draft your outline.

References

[edit]

Outline of proposed changes

[edit]

Click on the edit button to draft your outline.